Cannabinoids Manufacturing

Your Manufacturing Partner for Cannabinoid APIs

Leveraging decades of expertise in licensing and scale up, Purisys offers cannabinoid-focused companies a fully integrated supply chain for synthetic cannabinoid-based APIs.

The Regulatory Insights You Need to Succeed

Purisys has regulatory filings and the know-how to make dozens of APIs, and we offer a fully operational global supply chain, exporting to more than 40 countries – with full international regulatory compliance.

Our commitment to handling standards combines with our global logistical experience to offer a broad lineup of manufacturing and personnel assets for the development, manufacture, and support of cannabinoid-derived APIs.

Our flagship, 17,000-square-foot innovation center and manufacturing facility in Athens, Georgia, is staffed by teams with decades of experience in complex high-barrier custom synthetic chemistry and manufacture of cannabinoid-derived APIs.

At a Glance

  • DEA-compliant manufacturing
  • Reference-standard synthesis and qualification
  • Process development and optimization
  • Analytical method development, optimization, validation, and transfer
  • Small-scale cGMP clinical and commercial manufacturing
  • Non-sterile, parenteral processing and milling
  • Product design and development
  • Pre-formulation development and testing
  • Milling and custom packing

Expertise. Experience. Scale.

Formed as a wholly owned subsidiary of Noramco, which began manufacturing commercial pharmaceutical ingredients in 1979, Purisys now has decades of experience in high-barrier, custom synthetic chemistry and the manufacture of commercial and clinical-stage pharmaceuticals. We combine our pedigree in custom synthesis and GMP manufacturing to provide customers with a high-quality, broad portfolio of API manufacturing and testing services.

Connect With Us